tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT

Alaunos Therapeutics (TCRT) Financial Statements

662 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.673; its P/E ratio is -0.41; Alaunos Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.00K$ 1.00K-$ 4.00K-
Gross Profit$ 1.00K$ 1.00K-$ 4.00K-
EBIT$ -1.68M$ -365.00K$ -6.45M$ -8.20M$ -9.20M
EBITDA$ -1.68M$ -139.00K$ -5.78M$ -6.63M$ -8.03M
Net Income Common Stockholders$ -1.68M$ -7.84M$ -8.48M$ -8.77M$ -10.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.14M$ 6.06M$ 11.94M$ 18.32M$ 37.43M
Total Assets$ 6.04M$ 8.26M$ 19.44M$ 27.93M$ 48.64M
Total Debt$ 0.00$ 0.00$ 1.17M$ 1.56M$ 13.60M
Net Debt$ -4.14M$ -6.06M$ -10.77M$ -16.75M$ -23.83M
Total Liabilities$ 1.24M$ 1.96M$ 5.54M$ 6.28M$ 19.13M
Stockholders Equity$ 4.80M$ 6.31M$ 13.90M$ 21.65M$ 29.51M
Cash Flow-
Free Cash Flow$ -1.92M$ -5.88M$ -6.37M$ -7.14M$ -9.40M
Operating Cash Flow$ -1.92M$ -7.38M$ -6.37M$ -7.00M$ -9.38M
Investing Cash Flow-$ 1.50M$ 1.00K$ -135.00K$ -23.00K
Financing Cash Flow---$ -11.98M$ -6.16M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis